Cargando…

A Study of Triple Negative Breast Cancer at a Tertiary Cancer Care Center in Southern India

BACKGROUND: Triple negative breast cancers (TNBCs) are a diverse and heterogeneous group of tumors that by definition lack estrogen and progesterone receptors and amplification of the HER-2 gene. The majority of the tumors classified as TNBCs are highly malignant, patients are usually young and only...

Descripción completa

Detalles Bibliográficos
Autores principales: Lakshmaiah, KC, Das, U, Suresh, TM, Lokanatha, D, Babu, GK, Jacob, LA, Babu, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250994/
https://www.ncbi.nlm.nih.gov/pubmed/25506489
http://dx.doi.org/10.4103/2141-9248.144917
_version_ 1782346981902909440
author Lakshmaiah, KC
Das, U
Suresh, TM
Lokanatha, D
Babu, GK
Jacob, LA
Babu, S
author_facet Lakshmaiah, KC
Das, U
Suresh, TM
Lokanatha, D
Babu, GK
Jacob, LA
Babu, S
author_sort Lakshmaiah, KC
collection PubMed
description BACKGROUND: Triple negative breast cancers (TNBCs) are a diverse and heterogeneous group of tumors that by definition lack estrogen and progesterone receptors and amplification of the HER-2 gene. The majority of the tumors classified as TNBCs are highly malignant, patients are usually young and only a subgroup of patients responds to conventional chemotherapy with a favorable prognosis. Various studies have been reported in western literature on TNBCs, all highlighting the poor prognosis of this subtype. However, extensive data from India is lacking. AIM: The aim of this study was to analyze the epidemiological and clinical profile of TNBCs at our institute. MATERIALS AND METHODS: This was the retrospective study carried out in Tertiary Cancer Care Center in South India. Case files of all breast cancer patients were reviewed from the hospital database registered in 1 year and TNBC patients were selected for the study. Patient's characteristic, treatment, and histological features were analyzed. RESULTS: A total of 322 patients were registered during the period of 1 year and 26% (84/322) of total patients were TNBC. Median age of presentation was 44.5 years. About 94% (79/84) of patients had first full-term delivery before the age of 30 years. The most common presenting symptom was left sided breast lump. Locally advanced and early breast cancer (EBC) was 51% (43/84) and 42% (36/84), respectively. Metastatic breast cancer was seen in five patients. The highest numbers of patients were node negative disease (36.9%) [31/84], followed by N1 30.95% (26/84). Most of the patients had high-grade tumor. 94% (34/36) of cases of EBC had undergone upfront modified radical mastectomy. Invasive ductal carcinoma was the predominant histology except one who had medullary carcinoma. Twenty-four patients received neoadjuvant chemotherapy (NACT). There was no pathological complete remission, but all patients responded to NACT. Metastatic disease was seen in five patients. All patients had bone metastasis. CONCLUSIONS: TNBCs are highly aggressive subtype, with high grade with limited treatment options and very poor prognosis. Incidence is more in our country than the western literature. Even in our country also the incidence is varies in different region. TNBCs are significantly associated with young aged patients. There was a lack of association between tumor size and lymph node positivity.
format Online
Article
Text
id pubmed-4250994
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-42509942014-12-12 A Study of Triple Negative Breast Cancer at a Tertiary Cancer Care Center in Southern India Lakshmaiah, KC Das, U Suresh, TM Lokanatha, D Babu, GK Jacob, LA Babu, S Ann Med Health Sci Res Original Article BACKGROUND: Triple negative breast cancers (TNBCs) are a diverse and heterogeneous group of tumors that by definition lack estrogen and progesterone receptors and amplification of the HER-2 gene. The majority of the tumors classified as TNBCs are highly malignant, patients are usually young and only a subgroup of patients responds to conventional chemotherapy with a favorable prognosis. Various studies have been reported in western literature on TNBCs, all highlighting the poor prognosis of this subtype. However, extensive data from India is lacking. AIM: The aim of this study was to analyze the epidemiological and clinical profile of TNBCs at our institute. MATERIALS AND METHODS: This was the retrospective study carried out in Tertiary Cancer Care Center in South India. Case files of all breast cancer patients were reviewed from the hospital database registered in 1 year and TNBC patients were selected for the study. Patient's characteristic, treatment, and histological features were analyzed. RESULTS: A total of 322 patients were registered during the period of 1 year and 26% (84/322) of total patients were TNBC. Median age of presentation was 44.5 years. About 94% (79/84) of patients had first full-term delivery before the age of 30 years. The most common presenting symptom was left sided breast lump. Locally advanced and early breast cancer (EBC) was 51% (43/84) and 42% (36/84), respectively. Metastatic breast cancer was seen in five patients. The highest numbers of patients were node negative disease (36.9%) [31/84], followed by N1 30.95% (26/84). Most of the patients had high-grade tumor. 94% (34/36) of cases of EBC had undergone upfront modified radical mastectomy. Invasive ductal carcinoma was the predominant histology except one who had medullary carcinoma. Twenty-four patients received neoadjuvant chemotherapy (NACT). There was no pathological complete remission, but all patients responded to NACT. Metastatic disease was seen in five patients. All patients had bone metastasis. CONCLUSIONS: TNBCs are highly aggressive subtype, with high grade with limited treatment options and very poor prognosis. Incidence is more in our country than the western literature. Even in our country also the incidence is varies in different region. TNBCs are significantly associated with young aged patients. There was a lack of association between tumor size and lymph node positivity. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4250994/ /pubmed/25506489 http://dx.doi.org/10.4103/2141-9248.144917 Text en Copyright: © Annals of Medical and Health Sciences Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Lakshmaiah, KC
Das, U
Suresh, TM
Lokanatha, D
Babu, GK
Jacob, LA
Babu, S
A Study of Triple Negative Breast Cancer at a Tertiary Cancer Care Center in Southern India
title A Study of Triple Negative Breast Cancer at a Tertiary Cancer Care Center in Southern India
title_full A Study of Triple Negative Breast Cancer at a Tertiary Cancer Care Center in Southern India
title_fullStr A Study of Triple Negative Breast Cancer at a Tertiary Cancer Care Center in Southern India
title_full_unstemmed A Study of Triple Negative Breast Cancer at a Tertiary Cancer Care Center in Southern India
title_short A Study of Triple Negative Breast Cancer at a Tertiary Cancer Care Center in Southern India
title_sort study of triple negative breast cancer at a tertiary cancer care center in southern india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250994/
https://www.ncbi.nlm.nih.gov/pubmed/25506489
http://dx.doi.org/10.4103/2141-9248.144917
work_keys_str_mv AT lakshmaiahkc astudyoftriplenegativebreastcanceratatertiarycancercarecenterinsouthernindia
AT dasu astudyoftriplenegativebreastcanceratatertiarycancercarecenterinsouthernindia
AT sureshtm astudyoftriplenegativebreastcanceratatertiarycancercarecenterinsouthernindia
AT lokanathad astudyoftriplenegativebreastcanceratatertiarycancercarecenterinsouthernindia
AT babugk astudyoftriplenegativebreastcanceratatertiarycancercarecenterinsouthernindia
AT jacobla astudyoftriplenegativebreastcanceratatertiarycancercarecenterinsouthernindia
AT babus astudyoftriplenegativebreastcanceratatertiarycancercarecenterinsouthernindia
AT lakshmaiahkc studyoftriplenegativebreastcanceratatertiarycancercarecenterinsouthernindia
AT dasu studyoftriplenegativebreastcanceratatertiarycancercarecenterinsouthernindia
AT sureshtm studyoftriplenegativebreastcanceratatertiarycancercarecenterinsouthernindia
AT lokanathad studyoftriplenegativebreastcanceratatertiarycancercarecenterinsouthernindia
AT babugk studyoftriplenegativebreastcanceratatertiarycancercarecenterinsouthernindia
AT jacobla studyoftriplenegativebreastcanceratatertiarycancercarecenterinsouthernindia
AT babus studyoftriplenegativebreastcanceratatertiarycancercarecenterinsouthernindia